Meanwhile, studies by our and other groups suggested that targeting PDE6D-KRAS interaction is an effective approach to tackle both KRAS wild type [9,11] and -mutated [17,21,22,23,24] cancer types. The gene discussed is PDE6D; the disease is cancer.